For more information or confidential assistance
800-306-3180
se habla español

Stephanie Reid

Stephanie Reid is a practicing attorney and writer. In her position as a staff writer for Drug Reporter, she is dedicated to raising consumer awareness about the dangers of both prescription and common over-the-counter products.

New Study Reveals Need for Clinical Clarification of Testosterone Side Effects

Byetta pancreatic cancer patient
For aging men, testosterone replacement therapy can help combat some of the physiological symptoms of decreasing testosterone levels – a condition known as “Low-T.” However, much like female hormone replacement therapy, Low-T treatments have come under increasing scrutiny for potential side effects and unexpected life-threatening ailments in patients receiving therapy... Read more »

Xarelto Lawsuits Consolidated Into Multi-District Litigation

Over the past several years, the highly-anticipated next-generation blood thinner Xarelto has transformed from an exciting new addition to the American drug market to a potentially dangerous, even life-threatening treatment. Xarelto, which was designed and manufactured by Bayer and Johnson & Johnson subsidiary Janssen, has been named in 21 federal... Read more »

Study Shows Benicar Linked to Severe Abdominal Problems

The popular blood pressure drug known as Benicar (olmesartan medoxomil) is becoming increasingly known for its propensity to cause users severe and debilitating abdominal discomfort – reportedly linked to the onset of a condition known as sprue-like enteropathy. Benicar belongs to a class of drugs known as angiotensin receptor blockers,... Read more »

Januvia Pancreatic Cancer Lawsuit Joins Federal MDL

The drug Januvia is a widely-popular diabetes treatment option known as an “incretin mimetic.” The drug is manufactured by pharmaceutical giant Merck Sharp & Dohme, Corp. (hereinafter, “Merck”) and is one of the top-selling diabetes medications to date. However, an increasing number of Januvia users are reporting the sudden and... Read more »